JPMorgan Downgrades ConforMIS (CFMS) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to JPMorgan Downgrades ConforMIS (CFMS) to Neutral

ConforMIS Reports First Quarter 2016 Financial Results and Updates Fiscal Year 2016 Revenue Guidance; Board of Directors Initiates CEO Succession Plan

May 12, 2016 4:06 PM EDT

BEDFORD, Mass., May 12, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the first quarter ended March 31, 2016.

Q1 Summary:

Total revenue of $20.3 million, up 38% year-over-year on a reported basis and up 40% year-over-year on a constant currency basisProduct revenue of $20.0 million, up 36% year-over-year on a reported basis and up 39% year-over-year on a constant currency basis... More